European Medicines Agency: Use EMA Guidance When Buying Medicines

European Medicines Agency (EMA) protects public health across the European Union by reviewing medicines, issuing safety alerts, and publishing product records you can use when buying drugs online. If a pharmacy or seller uses EU approval as a selling point, you should verify that claim on EMA's site before you order. I'll show you which EMA tools matter and how to use them fast.

How EMA helps

EMA publishes public assessment reports, summaries of product characteristics, and safety communications. Search the 'Find medicine' page to confirm a product’s marketing authorisation, see the approved uses, and check the manufacturer. Public assessment reports explain clinical data and sometimes list known side effects. Safety communications and direct healthcare professional communications announce recalls or new warnings - watch those closely for drugs you use often.

Quick checks before you order online

1) Verify approval: Look up the medicine name on EMA and confirm the exact brand and formulation. Generic names can vary; match the active ingredient. 2) Read the SmPC and patient leaflet: They tell approved doses, contraindications, and common side effects. 3) Confirm the marketing authorisation holder: If the online seller is not the authorised distributor, ask for proof. 4) Look for safety alerts: A recent EMA warning should make you pause on any purchase. 5) Check national regulators: EMA coordinates approvals, but national agencies manage distribution and can add country-specific guidance.

If a website claims a product is 'EMA approved' but provides no product code, no SmPC, or no manufacturer name, that’s a red flag. Real EMA approvals include clear documentation you can copy and paste into the regulator's search. Also watch for pricing claims tied to EU subsidies; EMA does not set retail prices.

If you have a bad reaction or suspect fake medicine, report it. EMA maintains EudraVigilance for adverse event tracking and lists contact points for national authorities. Reporting helps regulators detect issues faster and protect other patients.

Want practical examples? Use EMA checks when you read our drug guides like 'How to Safely Buy Xyzal Online', 'Where and How to Buy Famotidine Online', or reviews of inhalers like Advair and Ellipta. When a drug has a recent EMA update, it can change safety advice or recommended use - and that should change where and how you buy it.

Before you click buy, spend three minutes on EMA's site: confirm the product, read the patient leaflet, and check for safety alerts. Those three minutes cut risk and often point you to a licensed seller or tell you to ask a doctor first.

Hands-on: open EMA's 'Find medicine' and search by active substance or product name. Open the EPAR for clinical summaries and download the SmPC PDF. Compare packaging images and leaflet language to what the seller shows. Note the marketing-authorisation number and the marketing authorisation holder name. For biosimilars, review the comparability data under the product page. For urgent safety updates, check PRAC statements and recent safety alerts.

Stay alert, always.

Calls for Domperidone Ban Intensify as Link to Premature Deaths Surfaces

Posted By John Morris    On 22 Mar 2024    Comments (0)

Calls for Domperidone Ban Intensify as Link to Premature Deaths Surfaces

The independent journal Prescrire has demanded the removal of domperidone, marketed as Motilium, from the European market. This call to action is spurred by the medication's association with cardiac risks and premature deaths, despite its effectiveness in treating nausea and vomiting. Alternative treatments are being recommended.

READ MORE